2016-01-26T09:53:37-06:00 2015-06-30 382706146 YEO & YEO PC PO BOX 3275 SAGINAW MI 48605 990 2014-07-01 382117115 EVERSIGHT EVER 7347802119 4889 VENTURE DRIVE ANN ARBOR MI 48108 KEVIN W ROSS PRESIDENT & CEO 7347802119 2015-12-11 true BRIAN R DIXON P01321580 9897939830 2016-01-26 2014 2016-04-25 22:37:26Z KEVIN W ROSS 4889 VENTURE DRIVE ANN ARBOR MI 48108 28092145 false X WWW.EVERSIGHTVISION.ORG X 1986 MI TO PRESERVE AND RESTORE SIGHT, THROUGH TRANSPLANTATION, RESEARCH, EDUCATION, AND PARTNERSHIP. 17 17 197 17 155684 -232 6073 227600 15853383 15947474 590480 765188 6621710 7561651 23071646 24501913 112760 0 0 12600704 12969071 0 361413 10654058 10330154 23367522 23299225 -295876 1202688 37060830 44166181 22171812 28439923 14889018 15726258 X TO PRESERVE AND RESTORE SIGHT, THROUGH TRANSPLANTATION, RESEARCH, EDUCATION, AND PARTNERSHIP. false false 13923297 TISSUE RECOVERY, EVALUATION AND DISTRIBUTION PROGRAM - THE PURPOSE OF THIS PROGRAM IS THE RECOVERY, EXAMINATION, EVALUATION AND DISTRIBUTION OF HUMAN EYE TISSUE THAT HAS BEEN DONATED FOR SIGHT-RESTORING CORNEAL TRANSPLANTATION, AND FOR OPHTHALMIC RESEARCH INTO THE CAUSES AND CURES OF BLINDING EYE CONDITIONS. EYE TISSUE DONORS ARE THOSE WHO GENEROUSLY GAVE THEIR CONSENT TO DONATE ORGANS AND/OR TISSUES UPON THEIR DEATH, OR WHOSE FAMILY GAVE CONSENT FOR DONATION WHEN THE DONORS DEATH OCCURRED. THE BENEFICIARIES OF THIS PROGRAM INCLUDE CORNEA TRANSPLANT RECIPIENTS, WHO SUFFER FROM EYE INJURIES AND DISEASES THAT CAN LEAD TO BLINDNESS UNLESS THEY ARE TREATED THROUGH CORNEAL TRANSPLANTATION, AND THE MILLIONS OF OTHERS WHO CAN BE HELPED THROUGH SCIENTIFIC RESEARCH. 4105272 PUBLIC AND PROFESSIONAL EDUCATION - EVERSIGHTS PUBLIC EDUCATION PROGRAM ENGAGES THE COMMUNITY IN THE EYE-BANKS MISSION TO RESTORE SIGHT. THIS COMMUNITY ENGAGEMENT PROMOTES POSITIVE ATTITUDES TOWARD EYE, ORGAN AND TISSUE DONATION, AWARENESS OF THE NEED FOR EYE DONORS, VOLUNTEERISM, AND EDUCATION ABOUT EYE HEALTH AND SAFETY. A TEAM OF COMMUNITY ENGAGEMENT STAFF MEMBERS INTERACT WITH CONSTITUENTS THROUGHOUT THE EYE-BANKS SERVICE AREAS, PROMOTING THE LIFE AND SIGHT- SAVING MESSAGE OF EYE, ORGAN AND TISSUE DONATION. MANY MORE CONSTITUENTS ARE REACHED THROUGH SEMI-ANNUAL NEWSLETTERS, ENEWSLETTERS, ANNUAL REPORTS AND WEB CONTENT SHARING OUR MESSAGE OF SIGHT RESTORATION. THE PROFESSIONAL EDUCATION PROGRAM BUILDS AND MAINTAINS RELATIONSHIPS WITH HEALTHCARE PROFESSIONALS AND OTHERS DIRECTLY INVOLVED IN EYE TISSUE DONATION AND TRANSPLANTATION EFFORTS. EFFECTIVE COLLABORATION WITH THESE PROFESSIONALS ENABLES SUITABLE RECOVERY OF TISSUE FOR TRANSPLANTATION AND RESEARCH, TIMELY RETRIEVAL OF DONOR MEDICAL INFORMATION, SUCCESSFUL DISTRIBUTION OF TISSUE FOR TRANSPLANTATION, AND ADVOCACY OF RESEARCH AND DONATION. 1191613 EYE AND VISION RESEARCH PROGRAM - EVERSIGHT SEEKS TO RESTORE SIGHT BY ANY MEANS POSSIBLE. WHEN BLINDNESS CANNOT BE REVERSED THROUGH CORNEAL TRANSPLANTATION, THE EYE-BANK PURSUES OTHER AVENUES OF SIGHT RESTORATION BY SUPPORTING RESEARCH INTO THE CAUSES AND CURES OF BLINDING EYE CONDITIONS. THROUGH THE EYE AND VISION RESEARCH PROGRAM, NEW VISION RESEARCH INITIATIVES SUPPORTED BY EVERSIGHT BRING NEW IDEAS TO LIFE FOR THE TREATMENT AND PREVENTION OF VISION IMPAIRMENT AND BLINDNESS. THE FUNDING OBJECTIVE OF THIS PROGRAM IS ENVISIONED PRIMARILY AS SEED MONEY TO DEVELOP IDEAS, COLLECT DATA OR CARRY OUT PRELIMINARY LABORATORY WORK THAT FACILITATES APPLICATION FOR MORE EXTENSIVE SUPPORT BY LARGER PRIVATE OR GOVERNMENTAL AGENCIES. AWARDS ARE GENERALLY 15,000 EACH, AND TOTAL AWARD FUNDING IS APPROXIMATELY 150,000 AND 200,000 PER YEAR. WHEN RESEARCH AWARDS ARE GRANTED, AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A WRITTEN PROGRESS REPORT TO EVERSIGHT WITHIN 14 MONTHS. THE EYE-BANK, IN TURN, APPRISES ITS STAKEHOLDERS OF RESEARCH PROJECTS AND ACCOMPLISHMENTS. RESEARCHERS ARE EXPECTED TO NOTIFY THE EYE-BANK OF ANY ADDITIONAL FUNDING THEY OBTAIN IN THE FUTURE, RESULTING FROM THE WORK MADE POSSIBLE THROUGH THE EYE-BANK GRANT. THEY ARE ALSO ASKED TO ACKNOWLEDGE EVERSIGHTS SUPPORT IN ANY PUBLICATIONS OR PRESENTATIONS COVERING THE FUNDED PROJECT (S), AND TO PROVIDE COPIES OF PAPERS PUBLISHED AS A RESULT OF EYE-BANK FUNDING. 19220182 true true false false false false false false false true true false false true true false false true false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 79 0 true 197 true true true false false false false false false false false false X 17 17 false false false false false false false true true false false true true true true true true true true false MI X JULIE COLLINS 7347802119 4889 VENTURE DRIVE ANN ARBOR MI 48108 ADRIENNE LOGEMAN CHAIR 1.00 X X 0 0 0 SAID ISSA MD VICE CHAIR 1.00 X X 0 0 0 RAY TIGOL TREASURER 1.00 X X 0 0 0 JONATHAN LASS MD SECRETARY 1.00 X X 0 0 0 TIMOTHY CONNORS JD DIRECTOR 1.00 X 0 0 0 BUSHARAT AHMAD MD DIRECTOR 1.00 X 0 0 0 JAROLD ANDERSON DIRECTOR 1.00 X 0 0 0 GARY BABCOCK DIRECTOR 1.00 X 0 0 0 RASHID L BASHSHUR DIRECTOR 1.00 X 0 0 0 WILLIAM CONSTAD MD DIRECTOR 1.00 X 0 0 0 EDWARD HUNTER DIRECTOR 1.00 X 0 0 0 MATTHEW KRICHBAUM DIRECTOR 1.00 X 0 0 0 ESTHER LAMOTHE DIRECTOR 1.00 X 0 0 0 PETER J LATZ DIRECTOR 1.00 X 0 0 0 JULIE LOWERY PHD DIRECTOR 1.00 X 0 0 0 FLORENCE M JOHNSTON PRESIDENT EM 1.00 X 0 0 0 MARILYN R LINDENAUER PRESIDENT EM 1.00 X 0 0 0 KEVIN ROSS PRESIDENT/CE 40.00 X 210669 0 35211 CHARLES PIVONEY COO 40.00 X 169710 0 32546 JULIE COLLINS CFO 40.00 X 152257 0 24294 BRADLEY TENNANT SENIOR VP 40.00 X 155209 0 26715 KRISTEN MCCOY VP CLINICAL 40.00 X 145522 0 26233 MICHAEL O'KEEFE ED MIDWIRE S 40.00 X 142629 0 23466 JANICE ABLESON HR DIRECTOR 40.00 X 132632 0 10203 MARGARET CHAPLIN EXEC DIR. LE 40.00 X 130214 0 25424 CATHERINE MCCLORY COMPLIANCE & 40.00 X 113779 0 9046 1352621 213138 13 false true false AXIS GLOBAL SYSTEMS PO BOX 780108 MASPETH NY 11378 SHIPPING 538406 DUNHAM SQUARE LAND 10020 AURORA HUDSON RD STREETSBORO OH 44241 BUILDING RENT 239248 OSTRANDER CONSTRUCTION INC 2001 BUTTERFIELD RD SUITE 1120 DOWNERS GROVE IL 60515 BUILDER 239248 3 227600 227600 EYE TISSUE FEES 621990 15947474 15947474 15947474 144435 144435 4210985 3590232 620753 620753 620753 INTERCOMPANY CHARGES 900099 7373886 7373886 VISION SHARE INCOME 900099 155684 155684 OTHER INCOME 900099 32081 32081 7561651 24501913 23974194 155684 144435 792781 249199 537475 6107 9067031 7304786 1499954 262291 477192 390120 73031 14041 1861767 1470396 338800 52571 770300 594486 154660 21154 15962 15962 46525 46525 84547 84547 97422 1108 95839 475 289754 201857 87897 917402 710450 206952 153302 64935 88103 264 91114 44862 45862 390 270086 270086 139850 106286 33564 CLINICAL LAB & TECH EXP 5252756 5252756 FUNDING TO DCSP 1927565 1927565 MIDWIRE USER FEES 227500 227500 MISCELLANEOUS 217617 409 217052 156 598752 403381 191407 3964 23299225 19220182 3717630 361413 1025656 1251588 236953 140235 23540 25000 2333041 2174989 114688 129061 5793991 3791520 2166983 2002471 8283096 7645819 22876873 30797018 37060830 44166181 1617242 1692290 1804 8773 1585000 1463000 18967766 25275860 22171812 28439923 X 14691391 15427171 23540 125000 174087 174087 14889018 15726258 37060830 44166181 1202688 -365448 X false true X true false X 62828 9406 17759 6073 227600 323666 16332111 22060834 24329665 22268486 23321360 108312456 16394939 22070240 24347424 22274559 23548960 108636122 1399086 1399086 1399086 1399086 107237036 176876 198497 150312 154047 144435 824167 176876 198497 150312 154047 144435 824167 1490 1490 531 5359 68569 56300 32081 162840 16572346 22274096 24566305 22486396 23725476 109624619 0.97820 0.96820 0.01000 0.01000 X PART III, LINE 12 MISCELLANEOUS 162,840 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 174087 174087 174087 174087 168837 5250 174087 165447 3390 168837 160847 4600 165447 1.00000 false false 170000 170000 1685483 410590 1274893 485108 344528 140580 3097825 2730465 367360 355575 305937 49638 2002471 RECEIVABLE FROM RELATED ENTITY 30545466 DEPOSIT 193573 OTHER ASSETS 29405 INTEREST RECEIVABLE 28574 30797018 PAYABLE TO RELATED ENTITY 25125096 POST-RETIREMENT BENEFITS 150764 25275860 24051918 -365448 -365448 24417366 84547 84547 24501913 23214678 23214678 84547 84547 23299225 X X X false false false false false false false false false KEVIN ROSS PRESIDENT/CEO 210669 14142 21069 245880 CHARLES PIVONEY COO 169710 11957 20589 202256 JULIE COLLINS CFO 152257 10614 13680 176551 BRADLEY TENNANT SENIOR VP 155209 10745 15970 181924 KRISTEN MCCOY VP CLINICAL OPERATIO 145522 9925 16308 171755 MICHAEL O'KEEFE ED MIDWIRE SYSTEMS 142629 9843 13623 166095 MARGARET CHAPLIN EXEC DIR. LEBNJ 130214 9171 16253 155638 FORM 990, PAGE 2, PART III, LINE 4B INVOLVED IN EYE TISSUE DONATION AND TRANSPLANTATION EFFORTS. EFFECTIVE COLLABORATION WITH THESE PROFESSIONALS ENABLES SUITABLE RECOVERY OF TISSUE FOR TRANSPLANTATION AND RESEARCH, TIMELY RETRIEVAL OF DONOR MEDICAL INFORMATION, SUCCESSFUL DISTRIBUTION OF TISSUE FOR TRANSPLANTATION, AND ADVOCACY OF RESEARCH AND DONATION. FORM 990, PAGE 2, PART III, LINE 4C FUNDING IS APPROXIMATELY 150,000 AND 200,000 PER YEAR. WHEN RESEARCH AWARDS ARE GRANTED, AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A WRITTEN PROGRESS REPORT TO EVERSIGHT WITHIN 14 MONTHS. THE EYE-BANK, IN TURN, APPRISES ITS STAKEHOLDERS OF RESEARCH PROJECTS AND ACCOMPLISHMENTS. RESEARCHERS ARE EXPECTED TO NOTIFY THE EYE-BANK OF ANY ADDITIONAL FUNDING THEY OBTAIN IN THE FUTURE, RESULTING FROM THE WORK MADE POSSIBLE THROUGH THE EYE-BANK GRANT. THEY ARE ALSO ASKED TO ACKNOWLEDGE EVERSIGHTS SUPPORT IN ANY PUBLICATIONS OR PRESENTATIONS COVERING THE FUNDED PROJECT (S), AND TO PROVIDE COPIES OF PAPERS PUBLISHED AS A RESULT OF EYE-BANK FUNDING. FORM 990, PAGE 6, PART VI, LINE 11B THE 990 IS REVIEWED BY THE CEO AND CFO PRIOR TO FILING. COMPLETED 990 IS PROVIDED VIA E-MAIL TO ALL BOARD MEMBERS FOR COMMENTS AND QUESTIONS PRIOR TO FILING. FORM 990, PAGE 6, PART VI, LINE 12C THE POLICY IS REVIEWED DURING NEW EMPLOYEE ORIENTATION AND ANNUALLY WITH THE ENTIRE STAFF AND BOARD OF DIRECTORS. ANY POTENTIAL CONFLICTS OF INTEREST ARE REVIEWED BY SENIOR STAFF UPON DISCOVERY. FORM 990, PAGE 6, PART VI, LINE 15A A PERFORMANCE REVIEW IS CONDUCTED BY THE BOARD HR COMMITTEE WITH CEO; MERIT INCREASE IS RECOMMENDED BY THE HR COMMITTEE AND APPROVED BY THE BOARD. THE CEO IS NOT PART OF COMPENSATION DISCUSSION AND CEO DOES NOT PARTICIPATE IN THE SELECTION OF BOARD MEMBERS. THE CEO SALARY IS COMPARED TO SALARIES OF OTHER CEO'S AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. THE SOURCE OF SALARY INFORMATION IS PRIMARILY THE 990'S ISSUED BY PEER ORGANIZATIONS. FORM 990, PAGE 6, PART VI, LINE 15B PERFORMANCE REVIEW FOR OFFICERS AND KEY EMPLOYEES IS CONDUCTED BY THE EMPLOYEES' IMMEDIATE MANAGER; MERIT INCREASES ARE RECOMMENDED BY THE MANAGER AND APPROVED BY THE CEO. SALARIES OF OFFICERS AND KEY EMPLOYEES ARE COMPARED TO SALARIES OF OTHER SIMILAR POSITIONS AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. A REPORT IS PROVIDED TO THE HR COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. THE SOURCE OF SALARY INFORMATION IS PRIMARILY THE 990'S ISSUED BY PEER ORGANIZATIONS. FORM 990, PAGE 6, PART VI, LINE 19 GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. EVERSIGHT NEW JERSEY INC 77 BRANT AVE SUITE 100 CLARK NJ 07066 203345087 EYE BANK NJ 3 7 EVERSIGHT EVERSIGHT false EVERSIGHT MICHIGAN 4889 VENTURE DRIVE ANN ARBOR MI 48108 273107692 EYE BANK MI 3 7 EVERSIGHT EVERSIGHT false EVERSIGHT ILLINOIS 547 WEST JACKSON BLVD SUITE 600 CHICAGO IL 60661 273107617 EYE BANK IL 3 7 EVERSIGHT EVERSIGHT false MIDWIRE SYSTEMS 4889 VENTURE DRIVE ANN ARBOR MI 48108 383557111 EYE BANK MI 3 7 EVERSIGHT EVERSIGHT false EVERSIGHT OHIO 6700 EUCLID AVE SUITE 101 CLEVELAND OH 44103 455111431 EYE BANK OH 3 7 EVERSIGHT EVERSIGHT false EVERSIGHT INTERNATIONAL 4889 VENTURE DRIVE ANN ARBOR MI 48108 471671769 EYE BANK MI 3 7 EVERSIGHT EVERSIGHT false EVERSIGHT INTERNATIONAL HOLDINGS 4 BURNABY STREET HAMILTON BERMUDA BD N/A false false true true false false false false false false false false false true true true false false false false EVERSIGHT NEW JERSEY INC O 324046 COST EVERSIGHT NEW JERSEY INC B 328245 COST EVERSIGHT NEW JERSEY INC N 148645 COST EVERSIGHT MICHIGAN O 564738 COST EVERSIGHT MICHIGAN B 564911 COST EVERSIGHT MICHIGAN C 15413 COST EVERSIGHT ILLINOIS O 572325 COST EVERSIGHT ILLINOIS B 584034 COST EVERSIGHT ILLINOIS N 273470 COST EVERSIGHT ILLINOIS C 51963 COST MIDWIRE SYSTEMS O 1432930 COST MIDWIRE SYSTEMS M 227500 COST EVERSIGHT OHIO O 449908 COST EVERSIGHT OHIO B 450375 COST EVERSGITH OHIO N 288335 COST EVERSIGHT OHIO C 100000 COST EVERSIGHT INTERNATIONAL O 357633 COST EVERSIGHT INTERNATIONAL C 3504930 COST